Roivant Sciences's market cap is currently $7.65B. The company's EPS TTM is $-0.144; its P/E ratio is 1.93; Roivant Sciences is scheduled to report earnings on February 17, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	$ 124.80M	$ 61.28M	$ 55.29M	$ 23.80M	$ 67.69M
Gross Profit	$ 96.83M	$ 48.15M	$ 46.32M	$ 21.74M	$ 66.56M
Operating Income	$ 4.24B	$ -1.18B	$ -1.35B	$ -1.07B	$ -532.42M
EBITDA	$ 4.31B	$ -1.18B	$ -916.71M	$ -895.74M	$ -553.30M
Net Income	$ 4.35B	$ -1.01B	$ -845.26M	$ -809.23M	$ 1.20B
Balance Sheet
Cash & Short-Term Investments	$ 6.54B	$ 1.68B	$ 2.06B	$ 2.13B	$ 2.19B
Total Assets	$ 7.22B	$ 2.39B	$ 2.59B	$ 2.69B	$ 2.48B
Total Debt	$ 499.75M	$ 481.40M	$ 283.89M	$ 244.98M	$ 180.88M
Net Debt	$ -6.04B	$ -1.20B	$ -1.78B	$ -1.81B	$ -2.00B
Total Liabilities	$ 773.95M	$ 782.02M	$ 523.70M	$ 527.69M	$ 368.36M
Stockholders' Equity	$ 5.97B	$ 1.16B	$ 1.66B	$ 1.80B	$ 2.03B
Cash Flow
Free Cash Flow	$ -766.65M	$ -856.08M	$ -695.16M	$ -557.94M	$ -766.75M
Operating Cash Flow	$ -765.27M	$ -843.39M	$ -677.73M	$ -552.14M	$ -761.83M
Investing Cash Flow	$ 5.20B	$ -44.27M	$ 303.30M	$ -31.70M	$ 1.69B
Financing Cash Flow	$ 419.36M	$ 499.46M	$ 306.79M	$ 456.26M	$ 217.16M

Currency in USD

Roivant Sciences Earnings and Revenue History

Income Statement >

Roivant Sciences Debt to Assets

Balance Sheet >

Roivant Sciences Cash Flow

Cash Flow >

Roivant Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing